Bruker Corporation (NASDAQ:BRKR) finished Friday with an addition of $0.61 to close at $66.96, an upside of 0.92 percent. An average of 781,920 shares of common stock have been traded in the last five days. There was a gain of $0.75 in the past week, and it reached a new high 21 times over the past 12 months. The last 20 days have seen an average of 1,097,460 shares traded, while the 50-day average volume stands at 871,566.
BRKR stock has decreased by -9.94% in the last month. The company shares reached their 1-month lowest point of $64.43 on 08/08/23. With the stock rallying to its 52-week high on 05/04/23, shares of the company touched a low of $48.42 and a high of $84.84 in 52 weeks. It has reached a new high 17 times so far this year and lost -2.03% or -$1.39 in price. In spite of this, the price is down -21.07% from the 52-week high.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
Insider Transactions
BRKR stock investors should be aware that Bruker Corporation (BRKR) stock had its last reported insider trading activity 4 days ago on Aug 08. In this transaction, the insider spent $2,459,345. EXECUTIVE VICE PRESIDENT, CFO, Herman Gerald N, disposed of 14,242 shares at a price of $75.42 on Jun 16. The insider now owns more than $1,074,132 worth of shares. Prior to that, Director Kastner Marc A went on to Sale 11,146 shares at $75.22 each on May 19. An amount of $838,402 was transacted.
Valuation Metrics
Bruker Corporation (BRKR) has a trailing price-to-earnings (P/E) ratio of 31.06. The stock’s beta is 1.12. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 3.69, the price-to-book (PB) ratio at 8.33, and the price-to-cash flow ratio at 86.82.
Financial Health
The quick ratio of Bruker Corporation for the three months ended June 29 was 1.20, and the current ratio was 2.00, indicating that the company is able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.94 and a total debt to equity ratio of 1.04 for the quarter ending June 29. Bruker Corporation’s EBITDA margin for the year ending June 29 is 21.67%, while its operating margin for the same period stands at 15.90%. Its gross profit as reported stood at $1.31 billion compared to revenue of $2.53 billion.
Earnings Surprise
For the three-month period that ended June 29, Bruker Corporation had $1.12 billion in total debt. In the quarter under review, the net income was down than the previous quarter. The company posted a net income of $57.1 million in the quarter, while revenues of $76.5 million were grew 13.31%. The analyst consensus anticipated Bruker Corporation’s latest quarter earnings to come in at $0.48 per share, but it turned out to be $0.5, a 4.20% surprise. For the quarter, EBITDA amounted to $112.1 million. Shareholders own equity worth $146.85 million.
Technical Picture
From a technical analysis perspective, let’s take a brief look at Bruker Corporation (BRKR) price momentum. RSI 9-day as of the close on 11 August was 37.71%, suggesting the stock is Neutral, with historical volatility in this time frame at 32.92%.
As of today, BRKR’s price is $66.26 +1.13% or $0.75 from its 5-day moving average. BRKR is currently trading -9.62% lower than its 20-day SMA and -7.95% lower than its 100-day SMA. However, the stock’s current price level is -3.10% below the SMA50 and +14.17% above the SMA200.
The stochastic %K and %D were 18.00% and 13.54%, respectively, and the average true range (ATR) was 2.14. With the 14-day stochastic at 26.49% and the average true range at 2.17, the RSI (14) stands at 37.39%. The stock has reached -1.02 on the 9-day MACD Oscillator while the 14-day reading was at -2.00.
Analyst Ratings
UBS launched coverage on Bruker Corporation (NASDAQ: BRKR) in its analyst report released on October 21, 2022. The firm assigned the stock a Buy rating. The consensus rating for Bruker Corporation (BRKR) among analysts is Overweight. According to current brokerage recommendations, 1 brokerage firm advise that investors sell BRKR, while 4 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 0 analysts, while 5 others rate it as a “buy”.
What is BRKR’s price target for the next 12 months?
Analysts predict a range of price targets between $68.00 and $95.00, with a median target of $81.50. Taking a look at these predictions, the average price target given by analysts for Bruker Corporation (BRKR) stock is $82.20.
